CIK 0001873835 · <br>Emerging growth company
Immix Biopharma, Inc.
Sign in to watch- Ticker
- IMMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454869378
- Phone
- (888) 958-1084
- Business address
- 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
- Former names
- Immix Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-20 | Ng Carey Director | Conversion | +1,000,221 | $0.85 | $850K | 1,000,221 |
| 2021-12-20 | Ng Carey Director | Purchase | +25,000 | $5.00 | $125K | 1,025,221 |
| 2021-12-20 | Ng Carey Director | Conversion · Convertible Note | −0 | 0 | ||
| 2021-12-17 | Torchilin Vladimir P Scientific Co-Founder | Purchase | +2,200 | $4.47 | $10K | 902,200 |
Page 7 of 7 · 124 trades